Marlin Global Outperforms Benchmark with 3.1% July Return Amid Semiconductor Sell-Off

Strong July Performance Defies Market Volatility

Marlin Global (NZX:MLN) posted a sharp rebound in July 2026 with a gross portfolio return of +3.1% and an adjusted net asset value (NAV) return of +2.9%, comfortably outperforming its global benchmark which declined 3.6%. This outperformance stands out amid one of the most volatile months in recent memory, marked by sharp intra-month swings in US equity markets and a brutal sell-off in semiconductor stocks.

The fund’s defensive stance on semiconductor exposure proved prescient as the Philadelphia Semiconductor Index (SOX) plunged around 20%, its worst month since 2008. Marlin’s deliberate underweighting of cyclical chipmakers like SK Hynix (-32%) and Micron (-31%) cushioned the portfolio from the sector’s sharp correction, reversing a year-long drag on relative performance. This selective positioning highlights the fund’s cautious approach to the AI investment cycle, favouring companies with clearer revenue growth over those facing rising capital intensity.

Key Holdings Drive Gains Amid Sector Rotation

Tech giants Microsoft and Amazon were standout contributors, rallying 25% and 14% respectively in local currency. Microsoft’s fiscal Q4 earnings beat expectations with Azure cloud growth accelerating to 43%, and management forecasting 45% growth next quarter, reinforcing confidence in its AI investments. Amazon’s AWS cloud segment grew 37%, its fastest pace in 18 quarters, with operating income hitting US$16.6 billion, underpinning the company's expanding AI and semiconductor businesses, each surpassing US$25 billion in annualised revenue.

Healthcare tech company Dexcom also delivered a strong 24% gain, buoyed by solid revenue growth, improved margins, and positive clinical trial results expanding its market for continuous glucose monitoring. These gains demonstrate Marlin’s focus on quality growth companies across technology and healthcare sectors.

Team Expansion and Portfolio Rebalancing Ahead

July saw Marlin bolster its investment team with two new analysts, Daniel Moser and Ashton Olds, joining existing analysts Chris Waters and Christian McIntyre. This expansion aims to deepen sector expertise and research coverage, allowing the fund to assign specialists to key areas such as Technology, Consumer, and Healthcare. The enhanced team is expected to support upcoming portfolio adjustments planned for August, which will broaden both sector and geographic diversification.

No new stocks were added or exited in July, but the manager signalled several changes on the horizon to capture emerging opportunities and mitigate risks amid ongoing market uncertainty.

Geopolitical and Economic Headwinds Shape Market Dynamics

July’s market turbulence was compounded by renewed Middle East tensions, with a fragile US-Iran ceasefire breaking down and Brent crude oil prices surging 24% to near US$100 per barrel. Meanwhile, the US Federal Reserve kept interest rates steady but saw bond yields rise to their highest levels since early 2025, reflecting investor concerns over inflation and policy effectiveness under new Chair Kevin Warsh.

These factors contributed to a reassessment of the AI investment cycle, with investors increasingly distinguishing between companies delivering tangible revenue acceleration and those facing uncertain returns on heavy capital expenditure. Marlin’s portfolio construction reflects this selective stance, favouring hyperscale cloud providers and healthcare innovators over more commoditised semiconductor plays.

Portfolio Composition and Performance Metrics

As of 31 July, Marlin’s portfolio was heavily weighted towards North America (76%), with smaller allocations to Asia Pacific (10%) and Western Europe (9%). Sector exposure was led by Information Technology (26%), Consumer Discretionary (21%), and Health Care (19%). The top five holdings included Microsoft (8%), Amazon (7%), Mastercard (6%), Meta Platforms (5%), and Tencent (5%).

Despite the strong July return, Marlin’s total shareholder return remains negative over one and three years, reflecting broader market headwinds and the fund’s defensive positioning. The fund’s gross performance return over three years annualised is +5.7%, trailing the benchmark’s 17.1%, underscoring the challenges of navigating volatile markets while maintaining a long-term growth focus.